MedTrace Logo

Copeptin After Arginine Infusion in Polyuria-Polydipsia Syndrome

NCT01879137 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2017-07-11

No results posted yet for this study

Summary

the purpose of the study is to investigate whether arginine infusion is a new tool to differentiate patients with diabetes insipidus, primary polydipsia and healthy subjects.

Conditions

  • Healthy
  • Polyuria-polydipsia Syndrome

Sponsors & Collaborators

  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • Mirjam Christ-Crain, Prof. MD · University Hospital, Basel, Switzerland

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-06-30
Primary Completion
2017-05-31
Completion
2017-05-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01879137 on ClinicalTrials.gov